Reference:
FLCCC Alliance. (2021). I-MASS protocol. Retrieved from https://flccc.net/covid-19-protocols/
Summary:
The I-MASS protocol, developed by the Front Line COVID-19 Critical Care Alliance (FLCCC), outlines prevention and treatment strategies for COVID-19, particularly focusing on home treatment and mass distribution during outbreaks. For prevention, adults over 18 years are advised to take Ivermectin (18 mg weekly), Vitamin D (32000 IU daily), and a multivitamin. The early treatment protocol suggests a daily intake of Ivermectin (24 mg for five days) along with Melatonin (6 mg nightly), Aspirin (80 mg daily unless contraindicated), and antiseptic mouthwash. In cases of exposure, a repeat dose of Ivermectin is recommended after 48 hours. The protocol highlights Ivermectin’s anti-viral and anti-inflammatory properties, supported by various trials indicating significant reductions in recovery time, hospitalisation rates, and mortality. However, the safety of Ivermectin during pregnancy remains uncertain, particularly in the first trimester, necessitating a discussion with healthcare providers. This protocol aims to mitigate the impact of COVID-19, especially in resource-limited settings, providing a structured approach to treatment and prevention. Comprehensive data supporting these recommendations can be found on the FLCCC’s official website.